From 1960 to the mid 90s, investigators of the biological basis of aging devoted most of their effort to describing differences between young and old individuals, whether human or rodent. These investigators used whatever new sets of methods seemed most powerful at the time: first enzyme assays and tests for hormone concentrations, then tests for mRNA levels, and, most recently, similar evaluations of proteome and metabolome status. These surveys did a fine job of documenting and anatomizing the outcome of the aging process, but did not go far enough towards explaining the process that generated old individuals from healthy young ones, or the factors that caused this process to go slowly in people and elephants, faster in bats, dogs and horses, and very rapidly in mice and rats.
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The 1990s produced a sea change in how biogerontologists attack problems in aging. The discovery of single gene mutants that extend lifespan of worms, flies, and (in 1996) mice has gradually produced a fundamentally new approach to biogerontology. This new paradigm focuses not on comparing old with young, but instead to evaluating, or changing, in young adults, those factors hypothesized to underlie differences in rate of aging between the long-lived mutant and the corresponding control. The demonstration that nematode lifespan was increased by mutations that block responses to hormones related to insulin led to studies of similar mutations in other taxa, revealing the deep evolutionary roots of these hormone-dependent control circuits. In addition, evidence that C. elegans mutants with increased lifespan are resistant to many forms of lethal stress, such as heat, irradiation, oxidants, and heavy metals, triggered experiments designed to assess stress resistance in mice carrying anti-aging mutations and in mice that had been exposed to caloric restriction. The recognition that aging can also be slowed by low calorie and low methionine diets (Miller et al., 2005b; Orentreich et al., 1993; Weindruch and Walford, 1988) and by pharmaceutical inhibition of a critical protein kinase (mTOR) (Harrison et al., 2009) , justified work to look for similarities and differences among the genetic, nutritional, and pharmacological approaches to anti-aging intervention, with studies of genetically flexible models (C. elegans, D. melanogaster) blazing promising trails for slower, more expensive studies in rodents. In each case the focus is on young adults that differ not in their chronological age, but in their expected pace of future aging.
These new paradigms have generated a flood of recent discoveries and renewed enthusiasm to biological aging research, but have also focused their experiments on one species at a time, and thus ignored a potential goldmine of experimental material: variation in the rates of aging among the rich collection of species generated by natural selection. Within a species, there seems to be Ageing Research Reviews 10 (2011) 181-190 
